Upload
diana-crawford
View
213
Download
1
Tags:
Embed Size (px)
Citation preview
Dept. of Nephrology and Immunology Dept. of Nephrology and Immunology San Carlo Borromeo Hospital - MilanSan Carlo Borromeo Hospital - Milan
Giuseppe D’Amico MD, FRCPGiuseppe D’Amico MD, FRCP
OPPORTUNITIES FOR A CHRONIC DISEASE OPPORTUNITIES FOR A CHRONIC DISEASE OUTREACH PROGRAM IN CHINAOUTREACH PROGRAM IN CHINA
Bellagio, ISN Conference, March 26-28, 2004Bellagio, ISN Conference, March 26-28, 2004
0200400600800
10001200140016001800
USA Japan Taiwan HongKong
MainlandChina
Patients on Regular Dialysis Treatment at the end of 2002 (prevalence per million of population)
Greater China Region
(288 millions) (127 millions) (22.5 millions)
(7 millions) (1300 millions)
A full dialysis treatment program in Mainland China, similar to that already existing in Taiwan, assuming a comparable prevalence of ESRF (genetic background is identical), would imply that regular dialysis treatment should be made available to more than 2 million patients, an annual total cost for the Central Government of 100 billion dollars.The number of patients that should be treated in Mainland China alone is double that of the total number of patients being treated now in the entire world.
GUANGHZOU
HONGKONG
ZHUHAI
MACAU